92146-76-4 Usage
Uses
Used in Organic Synthesis:
(3-Benzyloxycyclobutyl)amine hydrochloride is used as a building block for the synthesis of various organic compounds, providing a versatile starting material for the creation of new molecules with potential applications in various industries.
Used in Medical Research:
(3-Benzyloxycyclobutyl)amine hydrochloride is used as a building block for the synthesis of pharmaceuticals and bioactive compounds, contributing to the development of new drugs and therapies for various medical conditions.
Used in Pharmaceutical Industry:
(3-Benzyloxycyclobutyl)amine hydrochloride is used as an intermediate in the synthesis of pharmaceuticals, aiding in the production of drugs with specific therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 92146-76-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,1,4 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 92146-76:
(7*9)+(6*2)+(5*1)+(4*4)+(3*6)+(2*7)+(1*6)=134
134 % 10 = 4
So 92146-76-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO.ClH/c12-10-6-11(7-10)13-8-9-4-2-1-3-5-9;/h1-5,10-11H,6-8,12H2;1H
92146-76-4Relevant academic research and scientific papers
CHEMICAL COMPOUNDS
-
Paragraph 0185-0187, (2021/04/02)
The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the disclosure have activity as Janus kinase (JAK) inhibitors and are useful in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK by administering a compound herein described.
HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS
-
Page/Page column 53, (2011/12/02)
Heteroaryloxycarbocyclyl compounds of formula (I), and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive -compulsive disorder, and the like. Formula (I)
